SCHEMBL4852464

SCHEMBL4852464

Cc1ccccc1-c1ccc(OCCN2CCCC2)c(C=CC(=O)c2ccccc2CN(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 8/20 0.50
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
MCHR1 Q99705 1/20 0.41
HRH1 P35367 1/20 0.40
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
DRD3 P35462 1/20 0.39
ALDH1A1 P00352 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854149 0.95 BACE1 (0.52) BACE1MEN1KMT2AKDM4EKEAP1
SCHEMBL4847720 0.94 BACE1 (0.51) BACE1MEN1KMT2AKDM4EKEAP1
SCHEMBL4855930 0.91 BACE1 (0.49) BACE1TDP1MEN1KMT2AGAA
SCHEMBL4852459 0.91 BACE1 (0.49) BACE1TDP1MEN1KMT2AGAA
SCHEMBL4847450 0.87 SLC6A9 (0.43) KDM4ESMN1; SMN2ESR1MCHR1HRH1
SCHEMBL4846416 0.87 SLC6A9 (0.39) BACE1KDM4ESMN1; SMN2HRH1KEAP1
SCHEMBL4855924 0.86 BACE1 (0.51) BACE1MEN1KMT2AKDM4EKEAP1
SCHEMBL4854144 0.86 BACE1 (0.51) BACE1MEN1KMT2AKDM4EKEAP1
SCHEMBL4847711 0.85 BACE1 (0.51) BACE1MEN1KMT2AKDM4EKEAP1
SCHEMBL4854623 0.85 BACE1 (0.51) BACE1MEN1KMT2AKDM4EKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed